2021
DOI: 10.1016/j.compbiomed.2021.104694
|View full text |Cite
|
Sign up to set email alerts
|

Natural products from Brazilian biodiversity identified as potential inhibitors of PknA and PknB of M. tuberculosis using molecular modeling tools

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 61 publications
0
8
0
Order By: Relevance
“…Ten compounds were identified as potential inhibitors of the enzyme [ 139 ]. In another study, 13 compounds against Mycobacterium tuberculosis were identified from NuBBE DB [ 140 ]. The molecules are inhibitors of the serine/threonine protein kinase, which is essential for the growth and survival of the pathogen [ 141 ].…”
Section: Latin American Natural Product Databasesmentioning
confidence: 99%
“…Ten compounds were identified as potential inhibitors of the enzyme [ 139 ]. In another study, 13 compounds against Mycobacterium tuberculosis were identified from NuBBE DB [ 140 ]. The molecules are inhibitors of the serine/threonine protein kinase, which is essential for the growth and survival of the pathogen [ 141 ].…”
Section: Latin American Natural Product Databasesmentioning
confidence: 99%
“…Ten compounds were identified as potential inhibitors of the enzyme [138]. In another study 13 compounds against Mycobacterium tuberculosis were identified from NuBBEDB [139]. The molecules are inhibitors of the serine/threonine protein kinase, which is essential for the growth and survival of the pathogen [140].…”
Section: Nubbedbmentioning
confidence: 99%
“…Likewise, some countries in Latin America have published their own public NPs databases such as the NuBBE DB from Brazil which contains more than 2000 NPs [28], and BIOFACQUIM from Mexico, which contains a total of 531 molecules [29]. Furthermore, NPs databases had been used as a repository to identify several promising candidates to be considered for further development for the treatment of diseases [30], such as Chagas disease [31,32], Tuberculosis [33], Leishmaniasis [34,35], Schistosomiasis [36], and COVID-19 [37]. The present work introduces the first version of the Peruvian Natural Products Database (PeruNPDB), describing its assembly, curation, and chemoinformatic characterization of molecular diversity and coverage in chemical space.…”
Section: Introductionmentioning
confidence: 99%